Exercise-based evaluations and interventions for pulmonary hypertension with connective tissue disorders

References

• Babu AS, Arena R, Myers J, et al. Exercise intolerance in pulmonary hypertension: mechanism, evaluation and clinical implications. Expert Rev Respir Med. 2016;10(9):979–990.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34–41.
   PubMed Web of Science ®Google Scholar
• Condliffe R, Howard LS. Connective tissue disease-associated pulmonary arterial hypertension. F1000Prime Rep. 2015;7:06.
   PubMedGoogle Scholar
• Zhao J, Wang Q, Liu Y, et al. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: a cohort study in China. Int J Cardiol. 2017;236:432–437.
   PubMed Web of Science ®Google Scholar
• Cavagna L, Codullo V, Ghio S, et al. Undiagnosed connective tissue diseases: high prevalence in pulmonary arterial hypertension patients. Medicine (Baltimore). 2016;95(39):e4827.
   PubMed Web of Science ®Google Scholar
• Ruiz-Cano MJ, Escribano P, Alonso R, et al. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension. J Heart Lung Transplant. 2009;28(6):621–627.
   PubMed Web of Science ®Google Scholar
• Fowler RM, Gain KR, Gabbay E. Exercise intolerance in pulmonary arterial hypertension. Pulm Med. 2012; 359204. doi: 10.1155/2012/359204.
   PubMedGoogle Scholar
• Sun XG, Hansen JE, Oudiz RJ, et al. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001;104(4):429–435.
   PubMed Web of Science ®Google Scholar
• Kovacs G, Herve P, Barbera JA, et al. An official European Respiratory Society statement: pulmonary haemodynamics during exercise. Eur Respir J. 2017 Nov 22;50(5):1700578.
   Web of Science ®Google Scholar
• Provencher S, Herve P, Sitbon O, et al. Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension. Eur Respir J. 2008;32(2):393–398.
   PubMed Web of Science ®Google Scholar
• Arena R, Cahalin LP, Borghi-Silva A, et al. The effect of exercise training on the pulmonary arterial system in patients with pulmonary hypertension. Prog Cardiovasc Dis. 2015;57(5):480–488.
   PubMed Web of Science ®Google Scholar
• Naeije R, Brimioulle S, Dewachter L. Biomechanics of the right ventricle in health and disease (2013 Grover Conference series). Pulm Circ. 2014;4(3):395–406.
   PubMed Web of Science ®Google Scholar
• Vonk Noordegraaf A, Westerhof BE, Westerhof N. The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension. J Am Coll Cardiol. 2017;69(2):236–243.
   PubMed Web of Science ®Google Scholar
• Guazzi M, Villani S, Generati G, et al. Right Ventricular Contractile Reserve and Pulmonary Circulation Uncoupling During Exercise Challenge in Heart Failure: pathophysiology and Clinical Phenotypes. JACC Heart Fail. 2016;4(8):625–635.
   PubMed Web of Science ®Google Scholar
• Lin AC, Strugnell WE, Seale H, et al. Exercise cardiac MRI-derived right ventriculo-arterial coupling ratio detects early right ventricular maladaptation in PAH. Eur Respir J. 2016;48(6):1797–1800.
   PubMed Web of Science ®Google Scholar
• Mainguy V, Maltais F, Saey D, et al. Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension. J Cardiopulm Rehabil Prev. 2010;30(5):319–323.
   PubMed Web of Science ®Google Scholar
• Tolle J, Waxman A, Systrom D. Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension. Med Sci Sports Exerc. 2008;40(1):3–8.
   PubMed Web of Science ®Google Scholar
• Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15(2):261–271.
   PubMed Web of Science ®Google Scholar
• Reiseter S, Gunnarsson R, Mogens Aalokken T, et al. Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study. Rheumatology (Oxford). 2018 Feb 1;57(2):255–262.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Kondoh Y, Fischer A. Recent advances in connective tissue disease related interstitial lung disease. Expert Rev Respir Med. 2017;11:591–603.
   PubMed Web of Science ®Google Scholar
• Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum. 2010;39(4):269–277.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Pitsiou GG, Siakka P, et al. Phenotyping Exercise Limitation in Systemic Sclerosis: the Use of Cardiopulmonary Exercise Testing. Resp: Int Rev of Thracic Dis. 2016;91(2):115–123.
   Google Scholar
• Crozier IG, Li E, Milne MJ, et al. Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol. 1990;65(16):1145–1148.
   PubMed Web of Science ®Google Scholar
• Puntmann VO, D’Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6(2):295–301.
   PubMed Web of Science ®Google Scholar
• Tedford RJ, Mudd JO, Girgis RE, et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail. 2013;6(5):953–963.
   PubMed Web of Science ®Google Scholar
• Overbeek MJ, Lankhaar JW, Westerhof N, et al. Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. Eur Respir J. 2008;31(6):1160–1166.
   PubMed Web of Science ®Google Scholar
• Hsu S, Houston BA, Tampakakis E, et al. Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension. Circulation. 2016;133(24):2413–2422.
   PubMed Web of Science ®Google Scholar
• Mathai SC, Hassoun PM. Pulmonary arterial hypertension in connective tissue diseases. Heart Fail Clin. 2012;8(3):413–425.
   PubMed Web of Science ®Google Scholar
• Rosato E, Romaniello A, Magri D, et al. Exercise tolerance in systemic sclerosis patients without pulmonary impairment: correlation with clinical variables. Clin Exp Rheumatol. 2014;32(6 Suppl 86):S-103–108.
   PubMed Web of Science ®Google Scholar
• Someya F, Mugii N, Oohata S. Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis. Clin Exp Rheumatol. 2016 34;Suppl 100(5):152–156.
   Google Scholar
• Chung L, Liu J, Parsons L, et al. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest. 2010;138(6):1383–1394.
   PubMed Web of Science ®Google Scholar
• Jaeger VK, Distler O, Maurer B, et al. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford). 2018 Mar 1;57(3):441–450.
   PubMed Web of Science ®Google Scholar
• Grunig E, Maier F, Ehlken N, et al. Exercise training in pulmonary arterial hypertension associated with connective tissue diseases. Arthritis Res Ther. 2012;14(3):R148.
   PubMed Web of Science ®Google Scholar
• Morris NR, Seale H, Harris J, et al. Gas exchange responses during 6-min walk test in patients with pulmonary arterial hypertension. Respirology. 2017;22(1):165–171.
   PubMed Web of Science ®Google Scholar
• van der Net J, Wissink B, van Royen A, et al. Aerobic capacity and muscle strength in juvenile-onset mixed connective tissue disease (MCTD). Scand J Rheumatol. 2010;39(5):387–392.
   PubMed Web of Science ®Google Scholar
• Paik JJ, Wigley FM, Mejia AF, et al. Independent Association of Severity of Muscle Weakness With Disability as Measured by the Health Assessment Questionnaire Disability Index in Scleroderma. Arthritis Care Res (Hoboken). 2016;68(11):1695–1703.
   PubMed Web of Science ®Google Scholar
• Corallo C, Cutolo M, Volpi N, et al. Histopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation. Ther Adv Musculoskelet Dis. 2017;9(1):3–10.
   PubMed Web of Science ®Google Scholar
• Frech T, Walker AE, Barrett-O’Keefe Z, et al. Systemic sclerosis induces pronounced peripheral vascular dysfunction characterized by blunted peripheral vasoreactivity and endothelial dysfunction. Clin Rheumatol. 2015;34(5):905–913.
   PubMed Web of Science ®Google Scholar
• Mostmans Y, Cutolo M, Giddelo C, et al. The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review. Autoimmun Rev. 2017;16(8):774–786.
   PubMed Web of Science ®Google Scholar
• Rossi P, Granel B, Marziale D, et al. Endothelial function and hemodynamics in systemic sclerosis. Clin Physiol Funct Imaging. 2010;30(6):453–459.
   PubMed Web of Science ®Google Scholar
• Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119.
   PubMed Web of Science ®Google Scholar
• Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J. 2012;33(23):2917–2927.
   PubMed Web of Science ®Google Scholar
• Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873–934.
   PubMed Web of Science ®Google Scholar
• Colquhoun D, Freedman B, Cross D, et al. Clinical exercise stress testing in adults (2014). Heart Lung Circ. 2015;24(8):831–837.
   PubMed Web of Science ®Google Scholar
• Berry NC, Manyoo A, Oldham WM, et al. Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice. Pulm Circ. 2015;5(4):610–618.
   PubMed Web of Science ®Google Scholar
• Babu AS, Arena R, Morris NR. Evidence on exercise training in pulmonary hypertension. Adv Exp Med Biol. 2017;1000:153–172.
   PubMedGoogle Scholar
• Babu AS, Myers J, Arena R, et al. Evaluating exercise capacity in patients with pulmonary arterial hypertension. Expert Rev Cardiovasc Ther. 2013;11(6):729–737.
   PubMedGoogle Scholar
• Oudiz RJ, Barst RJ, Hansen JE, et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol. 2006;97(1):123–126.
   PubMed Web of Science ®Google Scholar
• Hsu CH, Glassner C, Foreman AJ, et al. Treadmill testing improves survival prediction models in pulmonary arterial hypertension. Am Heart J. 2011;162(6):1011–1017.
   PubMed Web of Science ®Google Scholar
• Chia EM, Lau EM, Xuan W, et al. Exercise testing can unmask right ventricular dysfunction in systemic sclerosis patients with normal resting pulmonary artery pressure. Int J Cardiol. 2016;204:179–186.
   PubMed Web of Science ®Google Scholar
• ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
   PubMed Web of Science ®Google Scholar
• Holland AE, Spruit MA, Troosters T, et al. An official european respiratory society/american thoracic society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–1446.
   PubMed Web of Science ®Google Scholar
• Singh SJ, Puhan MA, Andrianopoulos V, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1447–1478.
   PubMed Web of Science ®Google Scholar
• Andrianopoulos V, Holland AE, Singh SJ, et al. Six-minute walk distance in patients with chronic obstructive pulmonary disease: which reference equations should we use? Chron Respir Dis. 2015;12(2):111–119.
   PubMed Web of Science ®Google Scholar
• Mathai SC, Puhan MA, Lam D, et al. The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186(5):428–433.
   PubMed Web of Science ®Google Scholar
• Garin MC, Highland KB, Silver RM, et al. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol. 2009;36(2):330–336.
   PubMed Web of Science ®Google Scholar
• Villalba WO, Sampaio-Barros PD, Pereira MC, et al. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest. 2007;131(1):217–222.
   PubMed Web of Science ®Google Scholar
• Rizzi M, Sarzi-Puttini P, Airoldi A, et al. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease. Clin Exp Rheumatol. 2015;33(4 Suppl 91):S142–147.
   PubMed Web of Science ®Google Scholar
• Kusunose K, Yamada H, Hotchi J, et al. Prediction of future overt pulmonary hypertension by 6-min walk stress echocardiography in patients with connective tissue disease. J Am Coll Cardiol. 2015;66(4):376–384.
   PubMed Web of Science ®Google Scholar
• Coghlan JG, Denton CP, Grunig E, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73(7):1340–1349.
   PubMed Web of Science ®Google Scholar
• Pinkstaff SO, Burger CD, Daugherty J, et al. Cardiopulmonary exercise testing in patients with pulmonary hypertension: clinical recommendations based on a review of the evidence. Expert Rev Respir Med. 2016;10(3):279–295.
   PubMed Web of Science ®Google Scholar
• Vandecasteele E, De Pauw M, De Keyser F, et al. Six-minute walk test in systemic sclerosis: a systematic review and meta-analysis. Int J Cardiol. 2016;212:265–273.
   PubMed Web of Science ®Google Scholar
• Dumitrescu D, Nagel C, Kovacs G, et al. Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis. Heart. 2017;103(10):774–782.
   PubMed Web of Science ®Google Scholar
• Welch CE, Brittain EL, Newman AL, et al. End Tidal Carbon Dioxide as a Prognostic Feature in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2017 Jun;14(6):896–902.
   Web of Science ®Google Scholar
• Perez-Penate GM, Rua-Figueroa I, Julia-Serda G, et al. Pulmonary arterial hypertension in systemic lupus erythematosus: prevalence and predictors. J Rheumatol. 2016;43(2):323–329.
   PubMed Web of Science ®Google Scholar
• Minai OA, Gudavalli R, Mummadi S, et al. Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;185(4):400–408.
   PubMed Web of Science ®Google Scholar
• Pandey A, Garg S, Khunger M, et al. Efficacy and safety of exercise training in chronic pulmonary hypertension: systematic review and meta-analysis. Circ Heart Fail. 2015;8(6):1032–1043.
   PubMed Web of Science ®Google Scholar
• Babu AS, Padmakumar R, Maiya AG, et al. Effects of exercise training on exercise capacity in pulmonary arterial hypertension: a systematic review of clinical trials. Heart Lung Circ. 2016;25(4):333–341.
   PubMed Web of Science ®Google Scholar
• Morris NR, Kermeen FD, Holland AE. Exercise-based rehabilitation programmes for pulmonary hypertension. The Cochrane Database of Syst Rev. 2017;1:CD011285.
   PubMedGoogle Scholar
• Shoemaker MJ, Wilt JL, Dasgupta R, et al. Exercise training in patients with pulmonary arterial hypertension: a case report. Cardiopulm Phys Ther J. 2009;20(4):12–18.
   PubMedGoogle Scholar
• Fox BD, Kassirer M, Weiss I, et al. Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension. J Card Fail. 2011;17(3):196–200.
   PubMed Web of Science ®Google Scholar
• Grunig E, Ehlken N, Ghofrani A, et al. Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Resp: Int Rev of Thracic Dis. 2011;81(5):394–401.
   Google Scholar
• Chan L, Chin LM, Kennedy M, et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest. 2013;143(2):333–343.
   PubMed Web of Science ®Google Scholar